0
Article |

Ipecac Is Not Innocuous

ROBERT B. ALLPORT, M.D.
AMA Am J Dis Child. 1959;98(6):786-787. doi:10.1001/archpedi.1959.02070020788016.
Text Size: A A A
Published online

Ipecac syrup and ipecac fluidextract are commonly used for a variety of reasons in pediatric practice.

This brief history of the difficulties following the ingestion of ipecac fluidextract is presented as a reminder of the differences between ipecac fluidextract and ipecac syrup, and the potential toxicity of each.

A 2½-year-old child, a son of a physician, ingested approximately six 4 mg. chlorpheniramine (Chlor-Trimeton) maleate tablets. The father, a surgeon then on rounds at the local hospital, consulted with a group of three pediatricians as to what would be appropriate therapy. It was the agreed consensus that the child should be given "ipecac," a teaspoonful every five minutes until vomiting ensued. The father obtained from the local hospital pharmacy a bottle of ipecac, fluidextract, dispensed by a substitute pharmacist who was on duty for this one day only. The near catastrophe that followed points up the fact that ipecac is not

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs